BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28273548)

  • 1. Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway.
    Zhao P; Chen Y; Yue Z; Yuan Y; Wang X
    Leuk Res; 2017 Jun; 57():20-26. PubMed ID: 28273548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma.
    Yang Y; Shi J; Gu Z; Salama ME; Das S; Wendlandt E; Xu H; Huang J; Tao Y; Hao M; Franqui R; Levasseur D; Janz S; Tricot G; Zhan F
    Cancer Res; 2015 Feb; 75(3):594-604. PubMed ID: 25589346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.
    Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M
    Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells.
    Katsara O; Mahaira LG; Iliopoulou EG; Moustaki A; Antsaklis A; Loutradis D; Stefanidis K; Baxevanis CN; Papamichail M; Perez SA
    Stem Cells Dev; 2011 Sep; 20(9):1549-61. PubMed ID: 21204633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ectopic high expression of transcription factor OCT4 on the "stemness" characteristics of human bone marrow-derived mesenchymal stromal cells.
    Guo X; Tang Y; Zhang P; Li S; Chen Y; Qian B; Shen H; Zhao N
    Stem Cell Res Ther; 2019 Jun; 10(1):160. PubMed ID: 31159871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cell culture using chitosan membranes on stemness marker genes in mesenchymal stem cells.
    Li Z; Tian X; Yuan Y; Song Z; Zhang L; Wang X; Li T
    Mol Med Rep; 2013 Jun; 7(6):1945-9. PubMed ID: 23589181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of oct4 in human bone marrow mesenchymal stem cells.
    Wei X; Shen CY
    Stem Cells Dev; 2011 Mar; 20(3):441-9. PubMed ID: 20594032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The three-dimensional collagen scaffold improves the stemness of rat bone marrow mesenchymal stem cells.
    Han S; Zhao Y; Xiao Z; Han J; Chen B; Chen L; Dai J
    J Genet Genomics; 2012 Dec; 39(12):633-41. PubMed ID: 23273767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
    Xu X; Yang J; Tang Y; Li J; Zhu Y; Lu H; Fei X
    Int J Clin Exp Pathol; 2014; 7(10):6705-15. PubMed ID: 25400750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of pluripotency-related genes is highly dependent on trichostatin A-assisted epigenomic modulation of porcine mesenchymal stem cells analysed for apoptosis and subsequently used for generating cloned embryos.
    Samiec M; Romanek J; Lipiński D; Opiela J
    Anim Sci J; 2019 Sep; 90(9):1127-1141. PubMed ID: 31298467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.
    Dabbah M; Attar-Schneider O; Tartakover Matalon S; Shefler I; Jarchwsky Dolberg O; Lishner M; Drucker L
    Carcinogenesis; 2017 Jul; 38(7):708-716. PubMed ID: 28838065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
    Xu S; Menu E; De Becker A; Van Camp B; Vanderkerken K; Van Riet I
    Stem Cells; 2012 Feb; 30(2):266-79. PubMed ID: 22102554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells.
    Du Y; Shao H; Moller M; Prokupets R; Tse YT; Liu ZJ
    Stem Cells; 2019 Jul; 37(7):865-875. PubMed ID: 30941836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2.
    Pierantozzi E; Gava B; Manini I; Roviello F; Marotta G; Chiavarelli M; Sorrentino V
    Stem Cells Dev; 2011 May; 20(5):915-23. PubMed ID: 20879854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells from bone marrow regulate invasion and drug resistance of multiple myeloma cells by secreting chemokine CXCL13.
    Zhang G; Miao F; Xu J; Wang R
    Bosn J Basic Med Sci; 2020 May; 20(2):209-217. PubMed ID: 31538911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.
    Garcia-Gomez A; De Las Rivas J; Ocio EM; Díaz-Rodríguez E; Montero JC; Martín M; Blanco JF; Sanchez-Guijo FM; Pandiella A; San Miguel JF; Garayoa M
    Oncotarget; 2014 Sep; 5(18):8284-305. PubMed ID: 25268740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cancer effects of Staphylococcal Enterotoxin type B on U266 cells co-cultured with Mesenchymal Stem Cells.
    Ejtehadifar M; Halabian R; Fooladi AAI; Ghazavi A; Mosayebi G
    Microb Pathog; 2017 Dec; 113():438-444. PubMed ID: 29170042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox2 suppression by miR-21 governs human mesenchymal stem cell properties.
    Trohatou O; Zagoura D; Bitsika V; Pappa KI; Antsaklis A; Anagnou NP; Roubelakis MG
    Stem Cells Transl Med; 2014 Jan; 3(1):54-68. PubMed ID: 24307698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma.
    Tai YT; Chang BY; Kong SY; Fulciniti M; Yang G; Calle Y; Hu Y; Lin J; Zhao JJ; Cagnetta A; Cea M; Sellitto MA; Zhong MY; Wang Q; Acharya C; Carrasco DR; Buggy JJ; Elias L; Treon SP; Matsui W; Richardson P; Munshi NC; Anderson KC
    Blood; 2012 Aug; 120(9):1877-87. PubMed ID: 22689860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.